Skip navigational links

FDA Regulatory Affinity Group


The FDA Regulatory Affinity Group addresses marketing approval process, risk evaluation and mitigation strategies, direct-to-consumer advertising, off-label issues, preemption (labeling), good manufacturing practices, product diversion, anti-counterfeiting, and prescription drug importation.


No image found
Andrea B. Anantharam Chair Hall Render Killian Heath & Lyman PC Troy, MI (248) 740-7505 Email


You must be a member of the Life Sciences Practice Group or a government, academic, or student member, or have paid for all-Practice Groups access to enroll in this Affinity Group. You will remain a member as long as you are a member of its sponsoring Practice Group or maintain membership in one of the aforementioned membership categories.

To enroll in this Affinity Group (or if you are not a member of the sponsoring Practice Group(s) and would like to join now), please contact the Member Satisfaction Center at or (202) 833-1100, #2 or complete and return the enrollment form.

© 2017 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105